Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)

Harmen R. Moes; Erik Buskens; Teus van Laar

doi:10.1186/s12883-024-03743-8

Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)

Harmen R. Moes^*, Erik Buskens, Teus van Laar

^*Corresponding author voor dit werk

Onderzoeksoutput

20 Downloads (Pure)

Samenvatting

Following publication of the original article [1], the authors reported that the reference details to Antonini et al., 2024 (the other commentary in Matters Arising) are not correct. The correct details of the reference should be “Antonini A., Chaudhuri K.R., Domingos J., Jimenez-Shahed J., Wright J., Yan C.H., Alobaidi A., Bergmann L., Onuk K., Harmer L. and Malaty I. A. Response to letter to the editor regarding “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”. BMC Neurology. 2024. https://doi.org/10.1186/s12883-024-03691-3”. The original article [1] has been updated.

Originele taal-2	English
Artikelnummer	240
Aantal pagina's	1
Tijdschrift	BMC NEUROLOGY
Volume	24
DOI's	https://doi.org/10.1186/s12883-024-03743-8
Status	Published - 10-jul.-2024

Toegang tot document

10.1186/s12883-024-03743-8Licentie: CC BY

Correction- Comment on “Does the 5-2- 1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”Final publisher's version, 610 KBLicentie: CC BY

Handle.net

Permanente koppeling

Andere bestanden en links

Link naar publicatie in Scopus

Vingerafdruk

Duik in de onderzoeksthema's van 'Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)'. Samen vormen ze een unieke vingerafdruk.

1 Comment/Letter to the editor

Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”
Moes, H. R., Buskens, E. & van Laar, T., dec.-2024, In: BMC NEUROLOGY. 24, 1, 4 blz., 189.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand
1 Citaat (Scopus)

35 Downloads (Pure)

Citeer dit

Moes, H. R., Buskens, E., & van Laar, T. (2024). Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2). BMC NEUROLOGY, 24, Artikel 240. https://doi.org/10.1186/s12883-024-03743-8

@article{9f44a077614641e080a0b4eaf7879288,

title = "Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson{\textquoteright}s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)",

abstract = "Following publication of the original article [1], the authors reported that the reference details to Antonini et al., 2024 (the other commentary in Matters Arising) are not correct. The correct details of the reference should be “Antonini A., Chaudhuri K.R., Domingos J., Jimenez-Shahed J., Wright J., Yan C.H., Alobaidi A., Bergmann L., Onuk K., Harmer L. and Malaty I. A. Response to letter to the editor regarding “Does the 5-2-1 criteria identify patients with advanced Parkinson{\textquoteright}s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”. BMC Neurology. 2024. https://doi.org/10.1186/s12883-024-03691-3”. The original article [1] has been updated.",

author = "Moes, {Harmen R.} and Erik Buskens and {van Laar}, Teus",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = jul,

day = "10",

doi = "10.1186/s12883-024-03743-8",

language = "English",

volume = "24",

journal = "BMC NEUROLOGY",

issn = "1471-2377",

publisher = "BioMed Central Ltd.",

}

Moes, HR , Buskens, E & van Laar, T 2024, 'Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)', BMC NEUROLOGY, vol. 24, 240. https://doi.org/10.1186/s12883-024-03743-8

Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2). / Moes, Harmen R.; Buskens, Erik ; van Laar, Teus.
In: BMC NEUROLOGY, Vol. 24, 240, 10.07.2024.

Onderzoeksoutput

TY - JOUR

T1 - Correction to

T2 - Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)

AU - Moes, Harmen R.

AU - Buskens, Erik

AU - van Laar, Teus

PY - 2024/7/10

Y1 - 2024/7/10

N2 - Following publication of the original article [1], the authors reported that the reference details to Antonini et al., 2024 (the other commentary in Matters Arising) are not correct. The correct details of the reference should be “Antonini A., Chaudhuri K.R., Domingos J., Jimenez-Shahed J., Wright J., Yan C.H., Alobaidi A., Bergmann L., Onuk K., Harmer L. and Malaty I. A. Response to letter to the editor regarding “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”. BMC Neurology. 2024. https://doi.org/10.1186/s12883-024-03691-3”. The original article [1] has been updated.

AB - Following publication of the original article [1], the authors reported that the reference details to Antonini et al., 2024 (the other commentary in Matters Arising) are not correct. The correct details of the reference should be “Antonini A., Chaudhuri K.R., Domingos J., Jimenez-Shahed J., Wright J., Yan C.H., Alobaidi A., Bergmann L., Onuk K., Harmer L. and Malaty I. A. Response to letter to the editor regarding “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”. BMC Neurology. 2024. https://doi.org/10.1186/s12883-024-03691-3”. The original article [1] has been updated.

UR - http://www.scopus.com/inward/record.url?scp=85198028215&partnerID=8YFLogxK

U2 - 10.1186/s12883-024-03743-8

DO - 10.1186/s12883-024-03743-8

M3 - Erratum

C2 - 38987718

AN - SCOPUS:85198028215

SN - 1471-2377

VL - 24

JO - BMC NEUROLOGY

JF - BMC NEUROLOGY

M1 - 240

ER -

Correction to: Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries” (BMC Neurology, (2024), 24, 1, (189), 10.1186/s12883-024-03692-2)

Samenvatting

Toegang tot document

Handle.net

Andere bestanden en links

Vingerafdruk

Onderzoekersoutput

Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”

Citeer dit